Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. in vivo therapeutic
Show results for

Companies

News
Articles

Refine by
Date

  • Older

In Vivo Therapeutic Articles & Analysis

5 articles found

Based on Antibody Targeted Protein Degradation

Based on Antibody Targeted Protein Degradation

While KineTAC demonstrated excellent results in in vitro experiments, its in vivo experiments have not been extensively explored. Only pharmacokinetic studies have been presented, leaving room for further animal experiments to validate whether the in vitro effective dose might lead to potential "cytokine storm" side effects in vivo due to the intensity of ...

ByBOC Sciences


Exploring the Origins and Categorization of Microneedles

Exploring the Origins and Categorization of Microneedles

This refers to a cryomicroneedle shorter than 1 mm, which is loaded and stored with living mammalian cells in vivo and delivers therapeutic cells into the skin layer. When administering the drug, the patch-shaped device loaded with cryomicroneedle arrays is placed on the skin, and the cryomicroneedles penetrate into the skin, detach from the base of the device ...

ByCD Formulation


3D Bioprinting Of Prevascularised Implants For The Repair Of Critically-Sized Bone Defects

3D Bioprinting Of Prevascularised Implants For The Repair Of Critically-Sized Bone Defects

This dual approach was observed to provide higher level of vascularization and new bone formation in vivo. While applied in this case for bone regeneration, this technique could be easily adapted to prevascularise scaffolds to target regeneration of any tissue and organs. ...

ByRegenhu


Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells

Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells

Introduction The terminal sialic acids on the carbohydrate side chains of glycoproteins have a major impact on their overall properties, including their circulatory half-lives in vivo (Ngantung et al., 2006). Therefore, recombinant glycoprotein biologics intended for human therapeutic applications are usually manufactured in mammalian cell systems, which have ...

ByGlycoBac, LLC


Platform technologies to support brain-computer interfaces

Platform technologies to support brain-computer interfaces

New technologies are emerging that are leading to the development of highly intelligent, implantable sensors, activators, and mobile robots that will provide in vivo diagnosis, therapeutic interventions, and functional replacement. ...

ByComputational Diagnostics, Inc. (CDI)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT